— Know what they know.
Not Investment Advice

APUS Smart Money

Apimeds Pharmaceuticals US, Inc
1W: -55.6% 1M: +22.4% 3M: -62.6% YTD: -80.7% 1Y: -81.2%
$3.22
-0.88 (-21.46%)
 
Weekly Expected Move ±68.6%
$-1 $1 $3 $5 $8
AMEX · Healthcare · Biotechnology · Tech Score Neutral · Power 48 · $4.9M mcap · 563192 float · 267.23% daily turnover · Short 44% of daily vol

👔 Insider Trades

11 records
Date Name Title Type Shares Price Value Filing
2025-05-16 Emerson Erik C. officer: chief executive officer A-Grant/Award 750,000 $— $0 Filing
2025-05-16 Kim Christopher officer: chairman and cmo A-Grant/Award 250,000 $— $0 Filing
2025-05-14 Kim Christopher officer: chairman and cmo P-Purchase 7,730 $1.86 $14K Filing
2025-05-13 Kim Christopher officer: chairman and cmo P-Purchase 19,770 $1.82 $36K Filing
2025-05-12 Inscobee Inc. 10% owner P-Purchase 500,000 $4.00 $2.0M Filing
2025-05-12 Inscobee Inc. 10% owner C-Conversion 182,002 $2.60 $473K Filing
2025-05-12 Inscobee Inc. 10% owner C-Conversion 71,090 $2.60 $185K Filing
2025-05-12 Inscobee Inc. 10% owner C-Conversion 44,041 $2.60 $115K Filing
2025-05-12 Koo Jakap director P-Purchase 28,500 $1.99 $57K Filing
2025-05-12 Inscobee Inc. 10% owner C-Conversion 71,090 $2.60 $185K Filing
2025-05-12 Inscobee Inc. 10% owner C-Conversion 44,041 $2.60 $115K Filing

🏛️ Congressional Trades

0 records
Date Politician Chamber Type Amount Filing
No congressional trades found

🏦 Top Institutional Holders

0 holders
Holder Shares Value Date Reported Filing
No institutional holdings found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms